Press Releases

PharmaCyte Biotech Pancreatic Cancer Treatment to Target Recently Identified Forms of Pancreatic Cancer

SILVER SPRING, Md., Feb. 26, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, commented today on the implications of a major research breakthrough for pancreatic cancer. A recent publication in the scientific journal “Nature,”